nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethchlorvynol—GABRA1—hindbrain—amyotrophic lateral sclerosis	0.0713	0.14	CbGeAlD
Ethchlorvynol—GABRA1—brainstem—amyotrophic lateral sclerosis	0.0408	0.0802	CbGeAlD
Ethchlorvynol—GABRG2—medulla oblongata—amyotrophic lateral sclerosis	0.0323	0.0633	CbGeAlD
Ethchlorvynol—GABRG2—spinal cord—amyotrophic lateral sclerosis	0.0288	0.0565	CbGeAlD
Ethchlorvynol—GABRA1—medulla oblongata—amyotrophic lateral sclerosis	0.0285	0.0559	CbGeAlD
Ethchlorvynol—GABRA1—spinal cord—amyotrophic lateral sclerosis	0.0254	0.0498	CbGeAlD
Ethchlorvynol—GABRB3—medulla oblongata—amyotrophic lateral sclerosis	0.0248	0.0486	CbGeAlD
Ethchlorvynol—GABRG2—nervous system—amyotrophic lateral sclerosis	0.0242	0.0476	CbGeAlD
Ethchlorvynol—GABRG2—central nervous system—amyotrophic lateral sclerosis	0.0233	0.0458	CbGeAlD
Ethchlorvynol—GABRG2—cerebellum—amyotrophic lateral sclerosis	0.0228	0.0448	CbGeAlD
Ethchlorvynol—GABRB3—spinal cord—amyotrophic lateral sclerosis	0.0221	0.0434	CbGeAlD
Ethchlorvynol—GABRA1—nervous system—amyotrophic lateral sclerosis	0.0214	0.042	CbGeAlD
Ethchlorvynol—GABRB3—GABA receptor activation—KCNJ10—amyotrophic lateral sclerosis	0.021	0.0428	CbGpPWpGaD
Ethchlorvynol—GABRG2—GABA receptor activation—KCNJ10—amyotrophic lateral sclerosis	0.0206	0.0421	CbGpPWpGaD
Ethchlorvynol—GABRA1—central nervous system—amyotrophic lateral sclerosis	0.0206	0.0404	CbGeAlD
Ethchlorvynol—GABRA1—cerebellum—amyotrophic lateral sclerosis	0.0201	0.0395	CbGeAlD
Ethchlorvynol—GABRB3—nervous system—amyotrophic lateral sclerosis	0.0186	0.0365	CbGeAlD
Ethchlorvynol—GABRG2—brain—amyotrophic lateral sclerosis	0.0185	0.0364	CbGeAlD
Ethchlorvynol—GABRA1—GABA receptor activation—KCNJ10—amyotrophic lateral sclerosis	0.018	0.0368	CbGpPWpGaD
Ethchlorvynol—GABRB3—central nervous system—amyotrophic lateral sclerosis	0.0179	0.0352	CbGeAlD
Ethchlorvynol—GABRB3—cerebellum—amyotrophic lateral sclerosis	0.0175	0.0344	CbGeAlD
Ethchlorvynol—GABRA1—brain—amyotrophic lateral sclerosis	0.0164	0.0321	CbGeAlD
Ethchlorvynol—GABRB3—BDNF signaling pathway—PTPRF—amyotrophic lateral sclerosis	0.0147	0.0299	CbGpPWpGaD
Ethchlorvynol—GABRB3—brain—amyotrophic lateral sclerosis	0.0142	0.0279	CbGeAlD
Ethchlorvynol—GABRB3—Ion channel transport—TRPM7—amyotrophic lateral sclerosis	0.0119	0.0242	CbGpPWpGaD
Ethchlorvynol—GABRG2—Ion channel transport—TRPM7—amyotrophic lateral sclerosis	0.0117	0.0238	CbGpPWpGaD
Ethchlorvynol—GABRA1—Ion channel transport—TRPM7—amyotrophic lateral sclerosis	0.0102	0.0208	CbGpPWpGaD
Ethchlorvynol—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.00966	0.0197	CbGpPWpGaD
Ethchlorvynol—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.00948	0.0193	CbGpPWpGaD
Ethchlorvynol—GABRA1—SIDS Susceptibility Pathways—ECE1—amyotrophic lateral sclerosis	0.00894	0.0182	CbGpPWpGaD
Ethchlorvynol—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.00891	0.0182	CbGpPWpGaD
Ethchlorvynol—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.00875	0.0178	CbGpPWpGaD
Ethchlorvynol—GABRB3—BDNF signaling pathway—GRIA2—amyotrophic lateral sclerosis	0.00871	0.0178	CbGpPWpGaD
Ethchlorvynol—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.00829	0.0169	CbGpPWpGaD
Ethchlorvynol—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.00787	0.016	CbGpPWpGaD
Ethchlorvynol—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.00773	0.0158	CbGpPWpGaD
Ethchlorvynol—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.00765	0.0156	CbGpPWpGaD
Ethchlorvynol—GABRB3—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00726	0.0148	CbGpPWpGaD
Ethchlorvynol—GABRG2—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00713	0.0145	CbGpPWpGaD
Ethchlorvynol—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.00676	0.0138	CbGpPWpGaD
Ethchlorvynol—GABRB3—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.0067	0.0137	CbGpPWpGaD
Ethchlorvynol—GABRG2—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00658	0.0134	CbGpPWpGaD
Ethchlorvynol—GABRB3—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00647	0.0132	CbGpPWpGaD
Ethchlorvynol—GABRG2—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00635	0.013	CbGpPWpGaD
Ethchlorvynol—GABRA1—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00623	0.0127	CbGpPWpGaD
Ethchlorvynol—GABRB3—BDNF signaling pathway—MAPT—amyotrophic lateral sclerosis	0.00623	0.0127	CbGpPWpGaD
Ethchlorvynol—GABRB3—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00592	0.0121	CbGpPWpGaD
Ethchlorvynol—GABRG2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00581	0.0118	CbGpPWpGaD
Ethchlorvynol—GABRA1—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.00576	0.0117	CbGpPWpGaD
Ethchlorvynol—GABRA1—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.00576	0.0117	CbGpPWpGaD
Ethchlorvynol—GABRA1—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.00576	0.0117	CbGpPWpGaD
Ethchlorvynol—GABRA1—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00575	0.0117	CbGpPWpGaD
Ethchlorvynol—GABRB3—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00556	0.0113	CbGpPWpGaD
Ethchlorvynol—GABRA1—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00555	0.0113	CbGpPWpGaD
Ethchlorvynol—GABRB3—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.0055	0.0112	CbGpPWpGaD
Ethchlorvynol—GABRB3—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.0055	0.0112	CbGpPWpGaD
Ethchlorvynol—GABRG2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00546	0.0111	CbGpPWpGaD
Ethchlorvynol—GABRG2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.0054	0.011	CbGpPWpGaD
Ethchlorvynol—GABRG2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.0054	0.011	CbGpPWpGaD
Ethchlorvynol—GABRB3—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00513	0.0105	CbGpPWpGaD
Ethchlorvynol—GABRA1—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00508	0.0104	CbGpPWpGaD
Ethchlorvynol—GABRG2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00504	0.0103	CbGpPWpGaD
Ethchlorvynol—GABRB3—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00496	0.0101	CbGpPWpGaD
Ethchlorvynol—GABRB3—BDNF signaling pathway—SQSTM1—amyotrophic lateral sclerosis	0.00492	0.01	CbGpPWpGaD
Ethchlorvynol—GABRB3—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.0049	0.01	CbGpPWpGaD
Ethchlorvynol—GABRG2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00487	0.00993	CbGpPWpGaD
Ethchlorvynol—GABRG2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00482	0.00982	CbGpPWpGaD
Ethchlorvynol—GABRA1—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00477	0.00973	CbGpPWpGaD
Ethchlorvynol—GABRA1—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00472	0.00963	CbGpPWpGaD
Ethchlorvynol—GABRA1—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00472	0.00963	CbGpPWpGaD
Ethchlorvynol—GABRB3—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00453	0.00924	CbGpPWpGaD
Ethchlorvynol—GABRG2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00445	0.00908	CbGpPWpGaD
Ethchlorvynol—GABRA1—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00441	0.00898	CbGpPWpGaD
Ethchlorvynol—GABRA1—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00426	0.00868	CbGpPWpGaD
Ethchlorvynol—GABRB3—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00422	0.00859	CbGpPWpGaD
Ethchlorvynol—GABRB3—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00422	0.00859	CbGpPWpGaD
Ethchlorvynol—GABRA1—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00421	0.00858	CbGpPWpGaD
Ethchlorvynol—GABRG2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00414	0.00844	CbGpPWpGaD
Ethchlorvynol—GABRG2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00414	0.00844	CbGpPWpGaD
Ethchlorvynol—GABRB3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00414	0.00843	CbGpPWpGaD
Ethchlorvynol—GABRG2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00406	0.00828	CbGpPWpGaD
Ethchlorvynol—GABRA1—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00389	0.00793	CbGpPWpGaD
Ethchlorvynol—GABRB3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00376	0.00766	CbGpPWpGaD
Ethchlorvynol—GABRB3—BDNF signaling pathway—BDNF—amyotrophic lateral sclerosis	0.0037	0.00755	CbGpPWpGaD
Ethchlorvynol—GABRG2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00369	0.00752	CbGpPWpGaD
Ethchlorvynol—GABRA1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00362	0.00738	CbGpPWpGaD
Ethchlorvynol—GABRA1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00362	0.00738	CbGpPWpGaD
Ethchlorvynol—GABRA1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00355	0.00724	CbGpPWpGaD
Ethchlorvynol—GABRA1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00323	0.00657	CbGpPWpGaD
Ethchlorvynol—GABRA1—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.00298	0.00608	CbGpPWpGaD
Ethchlorvynol—GABRB3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00267	0.00543	CbGpPWpGaD
Ethchlorvynol—GABRG2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00262	0.00534	CbGpPWpGaD
Ethchlorvynol—GABRA1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00229	0.00466	CbGpPWpGaD
Ethchlorvynol—GABRB3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00227	0.00462	CbGpPWpGaD
Ethchlorvynol—GABRB3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00227	0.00462	CbGpPWpGaD
Ethchlorvynol—GABRG2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00223	0.00454	CbGpPWpGaD
Ethchlorvynol—GABRG2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00223	0.00454	CbGpPWpGaD
Ethchlorvynol—GABRB3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.00202	0.00412	CbGpPWpGaD
Ethchlorvynol—GABRG2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.00198	0.00404	CbGpPWpGaD
Ethchlorvynol—GABRA1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00195	0.00397	CbGpPWpGaD
Ethchlorvynol—GABRA1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00195	0.00397	CbGpPWpGaD
Ethchlorvynol—GABRB3—BDNF signaling pathway—CASP3—amyotrophic lateral sclerosis	0.00185	0.00377	CbGpPWpGaD
Ethchlorvynol—GABRA1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.00173	0.00353	CbGpPWpGaD
Ethchlorvynol—GABRA1—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.00149	0.00304	CbGpPWpGaD
Ethchlorvynol—GABRA1—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.00126	0.00258	CbGpPWpGaD
